• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.

作者信息

Kanamoto Y, Miyake Y, Suginaka H, Usui T

机构信息

Division of Microbiology, Hiroshima Prefectural Institute of Public Health, Japan.

出版信息

Chemotherapy. 1991;37(4):256-9. doi: 10.1159/000238864.

DOI:10.1159/000238864
PMID:1790724
Abstract

Nine antimicrobial agents, the new macrolides, rokitamycin and midecamycin acetate, and seven other antibiotics, tetracycline, minocycline, doxycycline, josamycin, erythromycin, spiramycin, and norfloxacin, were studied for their antimicrobial activity against 100 strains of Ureaplasma urealyticum, using a microtiter broth dilution technique. The new macrolides, rokitamycin and midecamycin acetate, had the highest activity, with the MIC against 90% of isolates tested (MIC90) being less than or equal to 0.05 microgram/ml. MICs90 of erythromycin, josamycin, doxycycline, minocycline and tetracycline ranged from 0.1 to 0.78 micrograms/ml. Norfloxacin was least active, with a MIC90 of 12.5 micrograms/ml. Five of 100 strains tested were resistant (MIC greater than or equal to 12.5 micrograms/ml) to tetracycline, and two were resistant to minocycline and doxycycline; all of these were susceptible to rokitamycin and midecamycin acetate.

摘要

相似文献

1
In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
Chemotherapy. 1991;37(4):256-9. doi: 10.1159/000238864.
2
The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.一些14元、15元和16元大环内酯类药物对葡萄球菌属、军团菌属、支原体属和溶脲脲原体的体外活性。
Drugs Exp Clin Res. 1991;17(2):91-9.
3
[In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].[图卢兹分离出的生殖支原体对抗生素的体外敏感性。新分子(大环内酯类和喹诺酮类)的研究]
Pathol Biol (Paris). 1992 May;40(5):479-82.
4
Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species.致病性诺卡氏菌属对大环内酯类抗生素红霉素、麦迪霉素和罗他霉素的灭活作用
Antimicrob Agents Chemother. 1994 Sep;38(9):2197-9. doi: 10.1128/AAC.38.9.2197.
5
[Drug sensitivity of Ureaplasma urealyticum, persisting in patients with chronic inflammatory diseases of the urogenital tract].[解脲脲原体在泌尿生殖道慢性炎症疾病患者体内持续存在时的药敏情况]
Zh Mikrobiol Epidemiol Immunobiol. 2003 Jul-Aug(4):81-5.
6
Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.解脲脲原体菌株抗菌药敏性测定的标准化方法及其对四环素、红霉素和罗沙米星的反应
Antimicrob Agents Chemother. 1981 Jul;20(1):53-8. doi: 10.1128/AAC.20.1.53.
7
[Susceptibility to macrolides against Mycoplasma pneumoniae isolated during 7 years].[7年间分离的肺炎支原体对大环内酯类药物的敏感性]
Kansenshogaku Zasshi. 1994 Feb;68(2):201-8. doi: 10.11150/kansenshogakuzasshi1970.68.201.
8
Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.罗他霉素及其他大环内酯类抗生素对L细胞中肺炎支原体的作用。
Antimicrob Agents Chemother. 1987 Nov;31(11):1843-5. doi: 10.1128/AAC.31.11.1843.
9
Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.塞尔维亚一家大学医院6年来收集的生殖系统样本中人型支原体和解脲脲原体的流行情况及抗生素敏感性
Indian J Dermatol Venereol Leprol. 2016 Jan-Feb;82(1):37-41. doi: 10.4103/0378-6323.172903.
10
In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.阿奇霉素对沙眼衣原体、解脲脲原体和人型支原体的体外活性与红霉素、罗红霉素和米诺环素的比较
J Chemother. 1993 Jun;5(3):155-8. doi: 10.1080/1120009x.1993.11739225.

引用本文的文献

1
Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.米卡霉素。对其抗菌活性、药代动力学特性及治疗潜力的综述。
Drugs. 1993 Oct;46(4):720-45. doi: 10.2165/00003495-199346040-00008.